Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.
Journal: Journal for immunotherapy of cancer
Published: August 10, 2026
ASO Visual Abstract: Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial.
Journal: Annals of surgical oncology
Published: July 25, 2026
EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 23, 2026
Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy.
Journal: The oncologist
Published: March 02, 2026
Beyond the Burden: Elevating Immunotherapy in Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 24, 2025
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial.
Journal: Annals of surgical oncology
Published: August 27, 2025
Single-photon emission computed tomography functional liver imaging to facilitate reirradiation for liver malignancies: A phase I trial.
Journal: JHEP reports : innovation in hepatology
Published: August 04, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT.
Journal: JCO precision oncology
Published: July 16, 2025
Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal Cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
Mutational and co-mutational landscape of early onset colorectal cancer.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: January 06, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 05, 2024
Last Updated: 09/26/2026